Dr. Lyudmila Sarder Receives Rave Reviews from Lakeland Regional Health and AdventHealth Cancer Institute for Research
21 août 2023 20h15 HE
|
Laekland Regional Health
Lakeland, FL, Aug. 21, 2023 (GLOBE NEWSWIRE) -- AdventHealth Cancer Institute proudly unveiled findings that mark a significant milestone in the cancer research field. Meanwhile, Lakeland Regional...
Over 1000 Orphan Drugs in Clinical Trials in the US - Eylea, Actimmune, Ravicti Among Key Approved Therapies
07 août 2023 06h43 HE
|
Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. ...
ODW Logistics Joins Pelotonia’s Celebration of 15 Years of One Goal for Cancer Research and Funding
03 août 2023 09h21 HE
|
ODW Logistics
COLUMBUS, Ohio, Aug. 03, 2023 (GLOBE NEWSWIRE) -- ODW Logistics, a fast-growing national third-party (3PL) specializing in integrated logistics solutions today announced the company’s support of...
AI in Oncology Market Report 2023-2033: Accelerated Drug Discovery and Targeted Therapies Driving Growth
21 juil. 2023 06h13 HE
|
Research and Markets
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in Oncology Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global revenue for...
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering
21 juil. 2023 02h15 HE
|
Turnstone Biologics Corp.
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing new medicines to treat and cure...
F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies
05 juil. 2023 08h00 HE
|
F-star Therapeutics, Inc.
LONDON, July 05, 2023 (GLOBE NEWSWIRE) -- F-star Therapeutics, an invoX company (“F-star”), today announced that it has entered into a strategic discovery collaboration and licence agreement with...
Advancements in Multiomics: Automation of Opal Staining on NanoVIP Saves 80% Reagent Cost and 90% Hands-on Time
22 mai 2023 11h58 HE
|
BioGenex
Fremont, California, May 22, 2023 (GLOBE NEWSWIRE) -- Omicsveu has achieved a milestone with its NanoVIP instrument – a slide-based automated staining system - fully automating the Opal manual...
Weichert’s Charity Outing Tees Off in August
19 mai 2023 06h10 HE
|
Weichert Companies
Morris Plains, NJ, May 19, 2023 (GLOBE NEWSWIRE) -- Weichert, Realtors will host its 23rd Annual Charity Outing on Thursday, Aug. 17, at Fiddler’s Elbow Country Club in Bedminster, NJ. The event,...
PDS Biotech to Present Updated Data at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Highlighting Combination of PDS0101 and KEYTRUDA® (pembrolizumab) in Head and Neck Cancer Patients
27 avr. 2023 08h00 HE
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., April 27, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...
Purdue Research Foundation monetizes Pluvicto royalty interests to fund further research at Purdue University
26 avr. 2023 08h00 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind. and NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Purdue Research Foundation, a private not-for-profit institute to advance the research of Purdue University, has received more...